Literature DB >> 20565317

Superior ophthalmic vein thrombosis in a patient with chronic myeloid leukemia receiving antifibrinolytic and thrombopoietin receptor agonist therapy.

Roman Shinder1, Patrick Oellers, Bita Esmaeli, Jade S Schiffman.   

Abstract

Isolated superior ophthalmic vein (SOV) thrombosis is a rare condition usually related to inflammation of the orbit or paranasal sinuses. Patients present with acute orbital signs, including proptosis, ophthalmoplegia, globe dystopia, and periorbital edema, and may have diminished vision secondary to optic neuropathy. SOV thrombosis is typically seen in the setting of septic cavernous sinus thrombosis, and antimicrobial therapy is the treatment of choice. We herein report what may be the first case of isolated SOV thrombosis related to hypercoagulability in a patient with cancer who was receiving antifibrinolytic and thrombopoietin receptor agonist medications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20565317     DOI: 10.1089/jop.2010.0008

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  2 in total

1.  Spontaneous superior ophthalmic vein thrombosis: a rare entity with potentially devastating consequences.

Authors:  L H Lim; R L Scawn; K M Whipple; S R Oh; M J Lucarelli; B S Korn; D O Kikkawa
Journal:  Eye (Lond)       Date:  2013-12-20       Impact factor: 3.775

2.  Bilateral isolated concurrent superior ophthalmic vein thrombosis in systemic lupus erythematosus.

Authors:  Kumar Sambhav; Omar Shakir; Kakarla V Chalam
Journal:  Int Med Case Rep J       Date:  2015-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.